Vaxxel

The startup develops live-attenuated vaccines targeting bronchiolitis and pneumonia, specifically against human metapneumovirus and human respiratory virus. By focusing on these critical respiratory diseases, the company aims to enhance treatment options and improve patient outcomes in the healthcare sector.

Traction 5/10

Villeurbanne, France · HQ

Founded 201911500+ followers

Biotechnology
Healthcare Technology

Updated 6 months ago

Funding

Raised to date

$2.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

2 founders

Denis Cavert

CEO

Manuel Rosa-Calatrava

Co-Founder

Product

Features

The startup develops live-attenuated vaccines targeting bronchiolitis and pneumonia, specifically against human metapneumovirus and human respiratory virus. By focusing on these critical respiratory diseases, the company aims to enhance treatment options and improve patient outcomes in the healthcare sector.